NCT07379398 2026-01-30
Iparomlimab and Tuvonralimab Injection Combined With SBRT in Patients With Early-Stage Non-Small Cell Lung Cancer
Tianjin Medical University Cancer Institute and Hospital
Phase 2 Not yet recruiting
Tianjin Medical University Cancer Institute and Hospital
Sun Yat-sen University
Sichuan University
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
Centro de Tratamiento e Investigación sobre Cáncer, Luis Carlos Sarmiento Angulo